Bio-Rad Laboratories, Inc. last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $656.4 million (+0.5% year over year) and diluted EPS of $17.02. It usually reports 30–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 11, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 12, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 30–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
656
+0.5%
|
459
+234.1%
|
17.02
+234.0%
|
|
Aug 4, 2026
35 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
651
-0.1%
|
371
+16.9%
|
13.85
+18.7%
|
|
Apr 30, 2026
30 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
592
+1.1%
|
-527
-923.6%
|
-19.55
-953.7%
|
|
Feb 12, 2026
43 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
693
+3.9%
|
720
+200.6%
|
26.65
+204.2%
|
|
Oct 29, 2025
29 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
653
+0.5%
|
-342
-152.3%
|
-12.70
-154.4%
|
|
Jul 31, 2025
31 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
652
+2.1%
|
318
+114.7%
|
11.67
+115.3%
|
|
May 1, 2025
31 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
585
-4.2%
|
64
-83.3%
|
2.29
-83.0%
|
|
Feb 13, 2025
44 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
668
-2.0%
|
-716
-304.7%
|
-25.57
-310.6%
|
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- BIO (NYSE), BIO-B (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hercules, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 12208
- Former names
- BIO RAD LABORATORIES INC (until Jun 18, 2018)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.